chr2-203956715-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_012092.4(ICOS):āc.451G>Cā(p.Val151Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000684 in 1,613,512 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_012092.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ICOS | NM_012092.4 | c.451G>C | p.Val151Leu | missense_variant | 3/5 | ENST00000316386.11 | NP_036224.1 | |
ICOS | XM_047444022.1 | c.454G>C | p.Val152Leu | missense_variant | 3/5 | XP_047299978.1 | ||
ICOS | XR_007073112.1 | n.503G>C | non_coding_transcript_exon_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ICOS | ENST00000316386.11 | c.451G>C | p.Val151Leu | missense_variant | 3/5 | 1 | NM_012092.4 | ENSP00000319476.6 | ||
ICOS | ENST00000435193.1 | c.451G>C | p.Val151Leu | missense_variant | 3/4 | 1 | ENSP00000415951.1 |
Frequencies
GnomAD3 genomes AF: 0.00217 AC: 330AN: 152144Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000876 AC: 220AN: 251192Hom.: 0 AF XY: 0.000715 AC XY: 97AN XY: 135738
GnomAD4 exome AF: 0.000530 AC: 774AN: 1461250Hom.: 1 Cov.: 30 AF XY: 0.000472 AC XY: 343AN XY: 726950
GnomAD4 genome AF: 0.00216 AC: 329AN: 152262Hom.: 1 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74446
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 1 Uncertain:2Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Jan 18, 2023 | This variant has been reported in the literature in 2 individuals with a clinical suspicion of immunodeficiency (1 as a homozygote, segregating with disease in 1 affected relative and 1 as a heterozygote (Abolhassani 2019 PMID:29921932, Bisgin 2021 PMID:33859323). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.6% [256/41450] including 1 homozygote; https://gnomad.broadinstitute.org/variant/2-203956715-G-C?dataset=gnomad_r3). This variant is present in ClinVar, with classifications ranging from Variant of Uncertain Significance to Likely Benign (Variation ID: 497910). Evolutionary conservation and computational prediction tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 06, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 26, 2016 | - - |
ICOS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 31, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at